EP2307007
Svingósín-1-fosfat viðtakastillar og notkun þeirra til að meðhöndla vöðvabólgu
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
22.7.2009EP published:
27.8.2014EP application number:
09780938.8
EP translation filed:
13.10.2014Grant published:
15.11.2014EPO information:
European Patent Register
Max expiry date:
21.7.2029Expiry date:
21.7.2017
Title:
SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION
Timeline
Today
22.7.2009EP application
27.8.2014EP Publication
13.10.2014Translation submitted
15.11.2014Registration published
21.7.2017Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
AHMED, Syed SohailAddress:
Siena, IT
Name:
LONDEI, MarcoAddress:
La Jolla, California, US
Name:
WRIGHT, TimothyAddress:
Swampscott, Massachusetts, US
Name:
GERGELY, PeterAddress:
Oberwil, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08161005Date:
23.7.2008Country:
EP
Classification
Categories:
A61K 31/397, A61P 21/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.6.2015
Expires: 21.7.2016
Payer: Árnason Faktor
Number: 8
Paid: 8.6.2016
Expires: 21.7.2017
Payer: Árnason Faktor